FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2279162094> ?p ?o ?g. }

• W2279162094 abstract "Epidemiological data on obesity are needed, particularly in patients with type 2 diabetes mellitus (T2DM) and high cardiovascular (CV) risk. We used the baseline data of liraglutide effect and action in diabetes: evaluation of CV outcome results—A long term Evaluation (LEADER) (a clinical trial to assess the CV safety of liraglutide) to investigate: (i) prevalence of overweight and obesity; (ii) relationship of the major cardiometabolic risk factors with anthropometric measures of adiposity [body mass index (BMI) and waist circumference (WC)]; and (iii) cardiometabolic treatment intensity in relation to BMI and WC. LEADER enrolled two distinct populations of high-risk patients with T2DM in 32 countries: (1) aged ≥50 years with prior CV disease; (2) aged ≥60 years with one or more CV risk factors. Associations of metabolic variables, demographic variables and treatment intensity with anthropometric measurements (BMI and WC) were explored using regression models (ClinicalTrials.gov identifier: NCT01179048). Mean BMI was 32.5 ± 6.3 kg/m2 and only 9.1 % had BMI <25 kg/m2. The prevalence of healthy WC was also extremely low (6.4 % according to International Joint Interim Statement for the Harmonization of the Metabolic Syndrome criteria). Obesity was associated with being younger, female, previous smoker, Caucasian, American, with shorter diabetes duration, uncontrolled blood pressure (BP), antihypertensive agents, insulin plus oral antihyperglycaemic treatment, higher levels of triglycerides and lower levels of high-density lipoprotein cholesterol. Overweight and obesity are prevalent in high CV risk patients with T2DM. BMI and WC are related to the major cardiometabolic risk factors. Furthermore, treatment intensity, such as insulin, statins or oral antihypertensive drugs, is higher in those who are overweight or obese; while BP and lipid control in these patients are remarkably suboptimal. LEADER confers a unique opportunity to explore the longitudinal effect of weight on CV risk factors and hard endpoints." @default.
• W2279162094 created "2016-06-24" @default.
• W2279162094 creator A5004424578 @default.
• W2279162094 creator A5018451703 @default.
• W2279162094 creator A5022933840 @default.
• W2279162094 creator A5027677153 @default.
• W2279162094 creator A5030909625 @default.
• W2279162094 creator A5037724247 @default.
• W2279162094 creator A5037824940 @default.
• W2279162094 creator A5073517018 @default.
• W2279162094 creator A5077595764 @default.
• W2279162094 creator A5080414941 @default.
• W2279162094 creator A5080463002 @default.
• W2279162094 creator A5081549147 @default.
• W2279162094 creator A5083610276 @default.
• W2279162094 date "2016-02-10" @default.
• W2279162094 modified "2023-10-06" @default.
• W2279162094 title "LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial" @default.
• W2279162094 cites W1410416944 @default.
• W2279162094 cites W1542476404 @default.
• W2279162094 cites W1598667444 @default.
• W2279162094 cites W1708175413 @default.
• W2279162094 cites W1798757189 @default.
• W2279162094 cites W1957007052 @default.
• W2279162094 cites W1982950261 @default.
• W2279162094 cites W1996716751 @default.
• W2279162094 cites W1998298719 @default.
• W2279162094 cites W2005848242 @default.
• W2279162094 cites W2006575348 @default.
• W2279162094 cites W2012208612 @default.
• W2279162094 cites W2012526350 @default.
• W2279162094 cites W2019071303 @default.
• W2279162094 cites W2026898341 @default.
• W2279162094 cites W2033185429 @default.
• W2279162094 cites W2033942337 @default.
• W2279162094 cites W2038292924 @default.
• W2279162094 cites W2045258255 @default.
• W2279162094 cites W2045440275 @default.
• W2279162094 cites W2057830475 @default.
• W2279162094 cites W2057836275 @default.
• W2279162094 cites W2064130493 @default.
• W2279162094 cites W2069183328 @default.
• W2279162094 cites W2079075230 @default.
• W2279162094 cites W2081225788 @default.
• W2279162094 cites W2100470148 @default.
• W2279162094 cites W2101297052 @default.
• W2279162094 cites W2110333911 @default.
• W2279162094 cites W2114616866 @default.
• W2279162094 cites W2116647894 @default.
• W2279162094 cites W2120471801 @default.
• W2279162094 cites W2123931921 @default.
• W2279162094 cites W2126763845 @default.
• W2279162094 cites W2131370619 @default.
• W2279162094 cites W2133977414 @default.
• W2279162094 cites W2143104968 @default.
• W2279162094 cites W2157288306 @default.
• W2279162094 cites W2162912569 @default.
• W2279162094 cites W2163710303 @default.
• W2279162094 cites W2165465852 @default.
• W2279162094 cites W2171136089 @default.
• W2279162094 cites W2607031541 @default.
• W2279162094 cites W2746751342 @default.
• W2279162094 cites W3025600498 @default.
• W2279162094 cites W4236673002 @default.
• W2279162094 cites W4238251256 @default.
• W2279162094 cites W4242364069 @default.
• W2279162094 cites W4244540230 @default.
• W2279162094 cites W807162506 @default.
• W2279162094 doi "https://doi.org/10.1186/s12933-016-0341-5" @default.
• W2279162094 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4750199" @default.
• W2279162094 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26864124" @default.
• W2279162094 hasPublicationYear "2016" @default.
• W2279162094 type Work @default.
• W2279162094 sameAs 2279162094 @default.
• W2279162094 citedByCount "42" @default.
• W2279162094 countsByYear W22791620942016 @default.
• W2279162094 countsByYear W22791620942017 @default.
• W2279162094 countsByYear W22791620942018 @default.
• W2279162094 countsByYear W22791620942019 @default.
• W2279162094 countsByYear W22791620942020 @default.
• W2279162094 countsByYear W22791620942021 @default.
• W2279162094 countsByYear W22791620942022 @default.
• W2279162094 countsByYear W22791620942023 @default.
• W2279162094 crossrefType "journal-article" @default.
• W2279162094 hasAuthorship W2279162094A5004424578 @default.
• W2279162094 hasAuthorship W2279162094A5018451703 @default.
• W2279162094 hasAuthorship W2279162094A5022933840 @default.
• W2279162094 hasAuthorship W2279162094A5027677153 @default.
• W2279162094 hasAuthorship W2279162094A5030909625 @default.
• W2279162094 hasAuthorship W2279162094A5037724247 @default.
• W2279162094 hasAuthorship W2279162094A5037824940 @default.
• W2279162094 hasAuthorship W2279162094A5073517018 @default.
• W2279162094 hasAuthorship W2279162094A5077595764 @default.
• W2279162094 hasAuthorship W2279162094A5080414941 @default.
• W2279162094 hasAuthorship W2279162094A5080463002 @default.
• W2279162094 hasAuthorship W2279162094A5081549147 @default.
• W2279162094 hasAuthorship W2279162094A5083610276 @default.
• W2279162094 hasBestOaLocation W22791620941 @default.
• W2279162094 hasConcept C126322002 @default.
• W2279162094 hasConcept C134018914 @default.

• next